References
- Alon U , SuretteMG, BarkaiN, LeiblerS. Robustness in bacterial chemotaxis. Nature397(6715) , 168–171 (1999).
- Goh KI , CusickME, ValleD, ChildsB, VidalM, BarabasiAL. The human disease network. Proc. Natl Acad. Sci. USA104(21) , 8685–8690 (2007).
- Jordan JD , LandauEM, IyengarR. Signaling networks: the origins of cellular multitasking. Cell103(2) , 193–200 (2000).
- Levine K , TinkelenbergAH, CrossF. The CLN gene family: central regulators of cell cycle Start in budding yeast. Prog. Cell Cycle Res.1 , 101–114 (1995).
- Little JW , ShepleyDP, WertDW. Robustness of a gene regulatory circuit. EMBO J.18(15) , 4299–4307 (1999).
- Weng G , BhallaUS, IyengarR. Complexity in biological signaling systems. Science284(5411) , 92–96 (1999).
- Yi TM , HuangY, SimonMI, DoyleJ. Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc. Natl Acad. Sci. USA97(9) , 4649–4653 (2000).
- Edelman GM , GallyJA. Degeneracy and complexity in biological systems. Proc. Natl Acad. Sci. USA98(24) , 13763–13768 (2001).
- Schernhammer ES , LadenF, SpeizerFE et al. Rotating night shifts and risk of breast cancer in women participating in the nurses‘ health study. J. Natl Cancer Inst. 93(20) , 1563–1568 (2001).
- Mancinelli L , CroninM, SadeeW. Pharmacogenomics: the promise of personalized medicine. AAPS Pharm. Sci.2(1) , e4 (2000).
- Sanchez C , LachaizeC, JanodyF et al. Grasping at molecular interactions and genetic networks in Drosophila melanogaster using FlyNets, an Internet database. Nucleic Acids Res. 27(1) , 89–94 (1999).
- Rappaport SM , SmithMT. Environment and disease risks. Science330(6003) , 460–461 (2010).
- Kitano H . Computational systems biology. Nature420(6912) , 206–210 (2002).
- Lal JA , BrandA. Functional dynamics: from biological complexity to translation and impact in healthcare systems. J. Comput. Sci. Syst. Biol.6 , 88–92 (2013).
- Sorensen K , BrandH. Health literacy: the essential catalyst for the responsible and effective translation of genome-based information for the benefit of population health. Public Health Genomics14(4–5) , 195–200 (2011).
- Tomris CB , NúriaM, RalfS, HansL, AngelaB. Public health perspective: from personalized medicine to personal health. Personal. Med.9(2) , 115–119 (2012).
- Lal JA , Schulte in den Bäumen T, Morré SA, Brand A. Public health and valorization of genome-based technologies: a new model. J. Transl. Med.9 , 207 (2011).
- Syurina E , BrandA, AmbrosinoE, FeronFJ. Concepts for the translation of genome-based innovations into public health: a comprehensive overview. Personal. Med.10(2) , 163–167 (2013).
- Crow MM , TuckerC. The American research university system as America‘s de facto technology policy. Science Public Policy28(1) , 2–10 (2001).
- Mullins CJ . Technology Transfer: a Roadmap. The Association of College and University Auditor Journal, KS, USA (1999).
- Rosenkotter N , VondelingH, BlancquaertI, MekelOC, KristensenFB, BrandA. The contribution of health technology assessment, health needs assessment, and health impact assessment to the assessment and translation of technologies in the field of public health genomics. Public Health Genomics14(1) , 43–52 (2011).
- Beskow LM , KhouryMJ, BakerTG, ThrasherJF. The integration of genomics into public health research, policy and practice in the United States. Community Genet.4(1) , 2–11 (2001).
- Brand A , LalJA, Public Health Genomics European N. European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies: the 2012 Declaration of Rome. Drug Metabol. Drug Interact.27(3) , 177–182 (2012).
- Lal JA , MalogajskiJ, VerweijSP et al. Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health. Public Health Genomics 16(1–2) , 50–61 (2013).
- Verhoef PC , LemonKN. Successful customer value management: key lessons and emerging trends. Eur. Management J.31(1) , 1–15 (2013).
- Claxton K , NeumannPJ, ArakiS, WeinsteinMC. Bayesian value-of-information analysis. An application to a policy model of Alzheimer‘s disease. Int. J. Technol. Assess. Health Care17(1) , 38–55 (2001).
- Stewart JJ , AllisonPN, JohnsonRS. Putting a price on biotechnology. Nature Biotechnol.19(9) , 813–817 (2001).
- Douw K , VondelingH, EskildsenD, SimpsonS. Use of the Internet in scanning the horizon for new and emerging health technologies: a survey of agencies involved in horizon scanning. J. Med. Internet Res.5(1) , e6 (2003).
- Brown IT , SmaleA, VermaA, MomandwallS. Medical technology horizon scanning. Australas. Phys. Eng. Sci. Med.28(3) , 200–203 (2005).
- Stevens A , GabbayJ. Needs assessment needs assessment. Health Trends23(1) , 20–23 (1991).
- Gutiérrez-Ibarluzea I , SimpsonS, Benguria-ArrateG. Early awareness and alert systems: an overview of EuroScan methods. Int. J. Technol. Assess. Health Care28(3) , 301–307 (2012).
- Packer C , Gutiérrez-IbarluzeaI, SimpsonS. The evolution of early awareness and alert methods and systems. Int. J. Technol. Assess. Health Care28(3) , 199–200 (2012).
- Lampe K , MäkeläM, GarridoMV et al. The HTA Core Model: A novel method for producing and reporting health technology assessments. Int. J. Technol. Assess. Health Care 25(Suppl. S2) , 9–20 (2009).
- Sullivan SD , WatkinsJ, SweetB, RamseySD. Health technology assessment in health-care decisions in the United States. Value Health12(Suppl. 2) , S39–S44 (2009).
- Douma KF , KarsenbergK, HummelMJ, Bueno-de-MesquitaJM, van Harten WH. Methodology of constructive technology assessment in health care. Int. J. Technol. Assess. Health Care23(2) , 162–168 (2007).
- Drummond MF , SculpherMJ, TorranceGW. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford, UK (2005).
- Eckermann S , KarnonJ, WillanAR. The value of value of information: best informing research design and prioritization using current methods. Pharmacoeconomics28(9) , 699–709 (2010).
- Steuten L , van de Wetering G, Groothuis-Oudshoorn K, Retèl V. A systematic and critical review of the evolving methods and applications of value of information in academia and practice. Pharmacoeconomics31(1) , 25–48 (2013).
- Varela-Lema L , Ruano-RavinaA, MotaTC et al. Post-introduction observation of healthcare technologies after coverage: the Spanish proposal. Int. J. Technol. Assess. Health Care 28(3) , 285–293 (2012).
- Policy TECH. Health Impact Assessment: Main Concepts and Suggested Approach. The Gothenburg Consensus Paper. WHO Regional Office for Europe (Ed.). Brussels, Belgium (1999).
- Mindell J , BowenC, HerriotN, FindlayG, AtkinsonS. Institutionalizing health impact assessment in London as a public health tool for increasing synergy between policies in other areas. Public Health124(2) , 107–114 (2010).
- Khoury MJ , GwinnM, YoonPW, DowlingN, MooreCA, BradleyL. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet. Med.9(10) , 665–674 (2007).
- Gutiérrez-Ibarluzea I . Personalised health care, the need for reassessment. A HTA perspective far beyond cost-effectiveness Ital. J. Public Health9(4) , (2012).
▪ Websites
- Executive Agency for Health and Consumers. Call 2013: tenders. http://ec.europa.eu/eahc/health/tenders_H09_2013.html
- IT Future of Medicine. www.itfom.eu
- Public Health Genomics. www.phgen.eu
- Green Park Collaborative. www.greenparkcollaborative.org
- Measuring and valuing customer relationships. How to develop the measures that drive profitable CRM strategies. www.business-intelligence.co.uk/reports/measure_crm/summary.asp
- The University of Birmingham (UK). An introduction to HCNA. www.birmingham.ac.uk/research/activity/mds/projects/HaPS/PHEB/HCNA/intro/index.aspx
- Division of Research and Economic Development. Technology transfer. http://cmsserv.ncat.edu/doclib/DORED,%20Outreach%20and%20Technology%20Transfer%20(How%20To%20Section)%20Web%20site,-5.pdf
- PKD Foundation. Drug development timeline. www.pkdcure.org/research/drug-development/timeline